Abbott Laboratories
Abbott Completes Acquisition of Exact Sciences, Strengthening Cancer Diagnostics Leadership
Summary
On March 23, 2026, Abbott Laboratories completed its acquisition of Exact Sciences Corporation, a leader in cancer screening and diagnostics. This strategic move positions Abbott as a leader in the fast-growing cancer screening and diagnostics segments, enhancing its ability to provide early cancer detection and personalized treatments. The acquisition, which was finalized under the terms of the Agreement and Plan of Merger dated November 19, 2025, saw Exact Sciences become a wholly owned subsidiary of Abbott. The transaction is expected to expand Abbott's presence in the $60 billion U.S. cancer screening and precision oncology diagnostics market, adding a new growth vertical to its high-single-digit growth expectations. Abbott's comprehensive suite of cancer detection and treatment products, including the Cologuard test and Oncotype DX, will now be complemented by Exact Sciences' offerings, such as the Oncodetect test and Cancerguard blood test. The acquisition is anticipated to transform cancer care by enabling more preventative, predictive, and personalized diagnostics.
Profitelligence Alerts
Get alerts for ABT
Be first to know when Abbott Laboratories files with the SEC.
Filing Categories
Advertisement
About Abbott Laboratories
Abbott Laboratories, a globally renowned company, specializes in the development and production of healthcare and medical products. Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott is a pivotal entity in the healthcare sector. The company provides essential products spanning diagnostics, medical devices, nutritional products, and branded generic pharmaceuticals. Notably, Abbott's extensive diagnostic solutions include immunoassays and molecular diagnostics, crucial for medical testing and healthcare management. Its medical devices division produces cardiovascular and neuromodulation products, enhancing patient care across diverse medical practices. Abbott’s nutritional segment, featuring well-known brands like Similac and Ensure, supports health and wellness across various demographics. Serving markets globally, Abbott Laboratories plays a critical role in advancing healthcare infrastructure and delivering innovative solutions that address evolving health challenges worldwide. As a significant player in the life sciences field, Abbott's contributions significantly influence patient outcomes and healthcare delivery systems.
Official SEC Documents
Advertisement